A Phase I Trial of Adenovector-Mediated Delivery of Interleukin-2 (AdIL-2) in High-Risk Localized Prostate Cancer

Cancer Gene Therapy - United Kingdom
doi 10.1038/sj.cgt.7700626
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Successful Phase 2 Trial of Ultrafocal Brachytherapy for Low/Intermediate Risk Prostate Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Phase 1/2 Study of Preoperative Docetaxel and Mitoxantrone for High-Risk Prostate Cancer

Cancer
Cancer ResearchOncology
2010English

Adenovector Engineered Interleukin-2 Expressing Autologous Plasma Cell Vaccination After High-Dose Chemotherapy for Multiple Myeloma - A Phase 1 Study

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2001English

Prospective Randomized Phase 2 Trial of Intensity Modulated Radiation Therapy With or Without Oncolytic Adenovirus-Mediated Cytotoxic Gene Therapy in Intermediate-Risk Prostate Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2014English

A Phase I Dose-Escalation Trial of Stereotactic Body Radiotherapy Using 4 Fractions for Patients With Localized Prostate Cancer

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2019English

Very High-Risk Localized Prostate Cancer: Outcomes Following Definitive Radiation

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

A Comprehensive Analysis of Steroid Hormones and Progression of Localized High-Risk Prostate Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2019English

Detection and Phenotyping of Circulating Tumor Cells in High-Risk Localized Prostate Cancer

Clinical Genitourinary Cancer
OncologyUrology
2015English

Prospective Phase II Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy